BWAY
HEALTHCAREBrainsway Ltd
$16.41-0.01 (-0.06%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BWAY Today?
No stock-specific AI insight has been generated for BWAY yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.31$17.18
$16.41
Fundamentals
Market Cap$657M
P/E Ratio91.2
EPS$0.18
Dividend Yield—
Dividend / Share—
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume144K
Avg Volume (10D)—
Shares Outstanding40.0M
BWAY News
20 articles- Are Medical Stocks Lagging Brainsway (BWAY) This Year?Yahoo Finance·May 4, 2026
- 5 Stocks With Recent Price Strength to Gain From April RallyYahoo Finance·May 4, 2026
- Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's WhyYahoo Finance·Apr 29, 2026
- BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026GlobeNewswire Inc.·Apr 29, 2026
- Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and BrainswayYahoo Finance·Apr 28, 2026
- 4 Medical Product Stocks to Buy From a Challenging IndustryYahoo Finance·Apr 27, 2026
- Exploring Three Undiscovered Gems in the Middle East MarketYahoo Finance·Apr 16, 2026
- BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) TherapyYahoo Finance·Apr 15, 2026
- Are Medical Stocks Lagging Alcon (ALC) This Year?Yahoo Finance·Apr 14, 2026
- Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should KnowYahoo Finance·Apr 13, 2026
- Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's WhyYahoo Finance·Apr 13, 2026
- BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 13, 2026
- New Strong Buy Stocks for April 13thYahoo Finance·Apr 13, 2026
- Zacks.com featured highlights include Cardinal Infrastructure, BrainsWay and Century AluminumYahoo Finance·Apr 6, 2026
- Why Brainsway (BWAY) Might be Well Poised for a SurgeYahoo Finance·Apr 2, 2026
- 3 Stocks With Recent Price Strength Despite a Tumultuous MarchYahoo Finance·Apr 1, 2026
- Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to AntidepressantsYahoo Finance·Mar 30, 2026
- Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?Yahoo Finance·Mar 26, 2026
- Here's Why Momentum in Brainsway (BWAY) Should Keep goingYahoo Finance·Mar 26, 2026
- BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDDYahoo Finance·Mar 26, 2026
All 20 articles loaded
Price Data
Open$16.27
Previous Close$16.42
Day High$16.51
Day Low$16.20
52 Week High$17.18
52 Week Low$4.31
52-Week Range
$4.31$17.18
$16.41
Fundamentals
Market Cap$657M
P/E Ratio91.2
EPS$0.18
Dividend Yield—
Dividend / Share—
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume144K
Avg Volume (10D)—
Shares Outstanding40.0M
About Brainsway Ltd
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—